Loading…
Second-largest private hospital chain in North India, running 14 NABH-accredited multi-specialty hospitals under the Park brand.
Second-largest private hospital chain in North India, running 14 NABH-accredited multi-specialty hospitals under the Park brand.
Earns from patients' hospital stays, procedures, tests and pharmacy sales, with payment coming from cash, private insurance and government health-insurance schemes, so the mix of payers and the number of occupied beds decide returns. New hospitals add capacity but take time to fill.
Moat: narrow (brand, installed base). Largest hospital network in Haryana with an entrenched NABH-accredited multi-specialty footprint.
Headquarters: Gurugram, India · Founded: 2005 · Employees: 6,423
Size Park Medi World (PARKHOSPS.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $1.15B, the 555th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹251.39 on 6 Nov 2026.
Performance Over six months the shares gained 2.2%, against -3.7% for the median peer and 0.0% for the India market (cap-weighted) — 8th highest of 20 in its peer set.
Growth Revenue grew 20.5% over the last twelve months (peer median +12.3%).
Valuation It trades at 28.3× forward earnings against a peer median of 38.1× (8th cheapest of 16).
Price implies For today's price to make sense, revenue must grow about 31% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is +20 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Next results Next results expected around 2 Dec 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹13.5B | ₹16.8B | ₹13.9B | ₹12.3B | ₹12.5B |
| Revenue growth | — | +21% | +13% | -2% | — |
| Gross profit | ₹8.53B | ₹9.55B | ₹7.39B | ₹6.66B | ₹7.69B |
| EBITDA | n/a | ₹4.53B | ₹3.83B | ₹3.18B | ₹3.96B |
| Net income | ₹2.04B | ₹2.58B | ₹2.02B | ₹1.53B | ₹2.20B |
| Free cash flow | n/a | ₹1.88B | ₹468M | ₹2.47B | ₹631M |
| Capital expenditure | n/a | ₹1.20B | ₹1.45B | ₹715M | ₹984M |
| Total debt | n/a | ₹3.64B | ₹6.82B | ₹6.87B | ₹5.76B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Park Medi World PARKHOSPS.NS | $1.15B | +2% | +21% | n/a | 28.3× | 30.5% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | $1.05B | +25% | +50% | 16% | 41.0× | n/a |
| Max Healthcare Institute MAXHEALTH.NS | $9.61B | -8% | +15% | 21% | 49.7× | 43.2% |
| Fortis Healthcare FORTIS.NS | $6.13B | -19% | +18% | 17% | 45.0× | 41.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PARKHOSPS.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -7.8% | 0.0% | 4th lowest of 20 |
| 6-month return | +2.2% | -3.7% | 8th highest of 20 |
| Distance from 52-week high | -17.6% | -21.8% | 10th highest of 20 |
| Revenue growth (TTM) | +20.5% | +12.3% | 5th highest of 21 |
| Forward P/E | 28.3× | 38.1× | 8th cheapest of 16 |
| Growth the price implies (Req g, 7 yrs) | 30.5% | 13.6% | most demanding of 15 |
| Growth delivered (Del g) | +10.2% | +10.3% | 7th lowest of 15 |
| Hurdle (Req g minus delivered) | +20.3 pp | +1.5 pp | 2nd most demanding of 15 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Park Medi World PARKHOSPS.NS | India | $1.15B | +2% | +21% | n/a | 28.3× | 30.5% | +10.2% |
| Ramsay Generale de Sante GDS.PA | France | $1.09B | -15% | +3% | 4% | n/a | 6.3% | +6.0% |
| Rhon-klinikum RHK.DE | Germany | $1.08B | +14% | +5% | 3% | 22.5× | n/a | n/a |
| CVS CVSG.L | United Kingdom | $1.23B | +20% | +6% | 11% | 14.3× | 13.7% | +6.9% |
| Raffles Medical BSL.SI | Singapore | $1.25B | -15% | -3% | 11% | 27.3× | -2.4% | +6.1% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.05B | +25% | +50% | 16% | 41.0× | n/a | n/a |
| Jupiter Life Line Hospitals JLHL.NS | India | $1,000M | +14% | +17% | 16% | 48.5× | n/a | n/a |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.34B | -4% | +23% | 22% | 39.4× | 30.2% | +21.2% |
| Spire Healthcare SPI.L | United Kingdom | $1.34B | +68% | +2% | 8% | 19.5× | 9.8% | +11.4% |
| Thomson Medical A50.SI | Singapore | $953M | -21% | +6% | 10% | n/a | 20.9% | +11.8% |
| HealthCare Global Enterprises HCG.NS | India | $950M | -2% | +14% | 8% | 67.3× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $940M | -7% | +11% | 20% | 18.2× | 0.7% | +19.7% |
| Sanbo Hospital Management 301293.SZ | China | $1.48B | -21% | +17% | 6% | 148.9× | n/a | n/a |
| Aevis Victoria AEVS.SW | Switzerland | $1.49B | +9% | +15% | -6% | 107.9× | 26.6% | +10.2% |
| Xi'an International Medical Investment 000516.SZ | China | $1.54B | 0% | -1% | -2% | n/a | 13.6% | +20.6% |
| Paras Healthcare PARASHLTH.NS | India | $844M | n/a | +24% | 11% | n/a | n/a | n/a |
| Sienna Senior Living SIA.TO | Canada | $1.63B | -11% | +16% | 10% | 38.1× | 19.6% | +8.6% |
| Extendicare EXE.TO | Canada | $1.87B | -9% | +31% | 9% | 19.4× | 11.2% | +8.5% |
| Huaxia Eye Hospital 301267.SZ | China | $1.92B | -16% | +2% | 15% | 24.7× | 3.8% | +10.4% |
| Kovai Medical Center & Hospital KOVAI.NS | India | $689M | +4% | +15% | 21% | n/a | 16.3% | +18.1% |
| Brookdale Senior Living BKD | United States | $2.15B | -31% | -4% | 5% | 127.7× | 22.4% | -1.4% |